Cargando…
Expression of DEK in pancreatic cancer and its correlation with clinicopathological features and prognosis
Background: The oncogene DEK, which was originally identified as part of the protein product of the DEK-CAN fusion oncogene, has been shown to promote tumorigenesis in a variety of cancer cell types. However, little is known about the expression and role of DEK in pancreatic ductal adenocarcinoma (P...
Autores principales: | Zhao, Ting, Qiu, Bijun, Zhou, Senhao, Ding, Guoping, Cao, Liping, Wu, Zhengrong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6400821/ https://www.ncbi.nlm.nih.gov/pubmed/30854097 http://dx.doi.org/10.7150/jca.27405 |
Ejemplares similares
-
Down-expression of CD36 in pancreatic adenocarcinoma and its correlation with clinicopathological features and prognosis
por: Jia, Shengnan, et al.
Publicado: (2018) -
Analysis of serum exosomal microRNAs and clinicopathologic features of patients with pancreatic adenocarcinoma
por: Que, Risheng, et al.
Publicado: (2013) -
High Expression of P38α and Preoperative Carbohydrate Antigen 19-9 Indicate Poor Prognosis in Patients with Pancreatic Ductal Adenocarcinoma
por: Chen, Jionghuang, et al.
Publicado: (2018) -
High expression of DEK predicts poor prognosis of gastric adenocarcinoma
por: Piao, Junjie, et al.
Publicado: (2014) -
DEK over expression as an independent biomarker for poor prognosis in colorectal cancer
por: Lin, Lijuan, et al.
Publicado: (2013)